Clinical Trials Logo

Clinical Trial Summary

Dexmedetomidine, an alpha 2-adrenoreceptor agonist, has been found to exerts an excellent influences on the filed of perineural block. It could shorten the onset time and prolong the duration of the nerve block and improved postoperative pain. However, Dexmedetomidine-induced bradycardia or hypotension has recently attracted considerable attention because of potentially grave consequences, including sinus arrest and refractory cardiogenic shock. A low dose may help minimize cardiovascular risks associated with dexmedetomidine. However, few studies have addressed the clinical effects of low-dose dexmedetomidine as an perineural adjuvant. The present study was designed to test the hypothesis that low-dose dexmedetomidine added to ropivacaine would safely enhance the duration of analgesia without adverse effects when compared with ropivacaine alone. Investigators will conduct a single-center, prospective, randomized, triple-blind, controlled trial in patients undergoing elective forearm and hand surgery under ultrasound-guided supraclavicular brachial plexus block using either ropivacaine or ropivacaine plus low-dose dexmedetomidine. The primary outcome is self-reported duration of analgesia . Secondary outcomes include onset time and duration of motor and sensory block, total postoperative analgesics, and safety assessment (adverse effects and postoperative abnormal sensation).


Clinical Trial Description

Dexmedetomidine, an alpha 2-adrenoreceptor agonist, has been found to exerts an excellent influences on the filed of perineural block. It could shorten the onset time and prolong the duration of the nerve block and improved postoperative pain. However, Dexmedetomidine-induced bradycardia or hypotension has recently attracted considerable attention because of potentially grave consequences, including sinus arrest and refractory cardiogenic shock. Although meta-analysis showed that perineural dexmedetomidine as a local anaesthetic adjuvant for neuraxial and peripheral nerve blocks produced reversible bradycardia in only 7% of brachial plexus block patients and no effect on the incidence of hypotension, various clinical studies reported a significant decrease in heart rate. A low dose may help minimize cardiovascular risks associated with dexmedetomidine. However, few studies have addressed the clinical effects of low-dose dexmedetomidine as an perineural adjuvant. The present study was designed to test the hypothesis that low-dose dexmedetomidine, which till today has not been reported in the literature, added to ropivacaine for brachial plexus block would safely enhance the duration of analgesia without adverse effects when compared with ropivacaine alone. Investigators will conduct a single-center, prospective, randomized, triple-blind, controlled trial in patients undergoing elective forearm and hand surgery under ultrasound-guided supraclavicular brachial plexus block using either 20 mL of 0.5% ropivacaine or 0.5% ropivacaine plus 30 microg dexmedetomidine. The primary outcome is self-reported duration of analgesia . Secondary outcomes include onset time and duration of motor and sensory block, total postoperative analgesics, and safety assessment (adverse effects including cardiovascular inhibitions and postoperative abnormal sensation). Data will be collected and analyzed in a blinded fashion. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02630290
Study type Interventional
Source Guangzhou First Municipal People’s Hospital
Contact
Status Completed
Phase Phase 4
Start date December 2015
Completion date June 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05846399 - CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) Phase 4
Withdrawn NCT04291170 - Comparison of Upper Extremity and Lower Extremity Function and Quick DASH N/A
Not yet recruiting NCT05060900 - Hand Ligament Reconstructions With Knee Collateral Ligament Allografts N/A
Active, not recruiting NCT05280704 - Traditional Dorsal Digital Block vs Volar Subcutaneous Digital Block N/A
Not yet recruiting NCT05003596 - Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand Phase 2/Phase 3
Completed NCT04068506 - Analgesic Effects of Gabapentin and Paracetamol Phase 4
Not yet recruiting NCT03937232 - Mirrored Movement Compared to Cross-education N/A
Completed NCT04328623 - Interest of Hypnosis on Pain Management During a Guided Echo Infiltration of the Hand N/A
Recruiting NCT04895891 - 3D Personalized Modelization of the Hand Using EOS Imaging System N/A
Completed NCT01210833 - Using HandTutor With Traumatic Hand Injuries: Characterizing the System N/A
Recruiting NCT06086392 - Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery Phase 4
Completed NCT05878509 - Reliability and Validity of the Tampa Scale for Kinesiophobia
Withdrawn NCT04027569 - PROMs To Improve Care- Standardized vs Patient Specific N/A
Completed NCT03345693 - Use of MoTrack Therapy in At-Home Hand Rehabilitation N/A
Completed NCT06112145 - Are Rehabilitation Results in Flexor Tendon Zone II Injuries as Bad as Feared? N/A
Completed NCT03496337 - Is AMPS a Responsive Tool for Assessing Change in ADL-abilities After Finger or Hand Surgery
Completed NCT02789852 - Evaluation of the Effectiveness of Night Orthosis in Treating Women With Symptomatic Osteoarthritis in the Interphalangeal Joint of the Dominant Hand N/A
Completed NCT02331004 - Effectiveness of an Intervention Program for Fine Motor Skills N/A
Completed NCT04486053 - Long-term Results of Pediatric Flexor Tendon Injuries
Completed NCT03458013 - Psychosocial Outcomes in Hand Therapy N/A